(1E,6E)-1,7-bis(4-(4-methylpiperazin-1-yl)phenyl)hepta-1,6-diene-3,5-dione | 1030861-23-4

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二芳基庚烷
• 英文名称: (1E,6E)-1,7-bis(4-(4-methylpiperazin-1-yl)phenyl)hepta-1,6-diene-3,5-dione
• 英文别名: (1E,6E)-1,7-bis[4-(4-methylpiperazin-1-yl)phenyl]hepta-1,6-diene-3,5-dione
• CAS: 1030861-23-4
• 化学式: C₂₉H₃₆N₄O₂
• 分子量: 472.63
• InChiKey: DDXGKVWWYPMZGU-FNCQTZNRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  35
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  47.1
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  4-(4-甲基哌嗪)苯甲醛 、 乙酰丙酮 在 boron trioxide 、 硼酸三丁酯 作用下， 以 乙酸乙酯 为溶剂， 反应 3.5h， 以50%的产率得到(1E,6E)-1,7-bis(4-(4-methylpiperazin-1-yl)phenyl)hepta-1,6-diene-3,5-dione
  参考文献：
  名称：

  Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer’s disease

  摘要：

  A series of novel curcumin analogues were designed, synthesized, and evaluated as potential multifunctional agents for the treatment of AD. The in vitro studies showed that these compounds had better inhibitory properties against A beta aggregation than curcumin. Superior anti-oxidant properties (better than the reference compound Trolox) of these compounds were observed by the oxygen radical absorbance capacity (ORAC) method and a cell-based assay using DCFH-DA as a probe. In addition they were able to chelate metals such as iron and copper and decrease metal-induced A beta aggregation. The structure-activity relationships were discussed. The results suggested that our curcumin analogues could be selected as multifunctional agents for further investigation of AD treatment. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.07.033

文献信息

• NOVEL CURCUMIN DERIVATIVE
  申请人：Takahashi Takashi

  公开号：US20100048901A1

  公开（公告）日：2010-02-25

  The present invention provides a novel compound that is structurally similar to curcumin and has a suppressive effect on Aβ aggregation, a degradative effect on Aβ aggregates, an inhibitory effect on β-secretase, and a protective effect on neurons. The novel compound is a compound represented by the following general formula (Ia) or a salt thereof: wherein R 1 represents a 4-hydroxy-3-methoxyphenyl group or the like, and R 2 represents a 1H-indol-6-yl group or the like.

  本发明提供了一种新型化合物，其结构类似于姜黄素，并具有抑制Aβ聚集、降解Aβ聚集体、抑制β-分泌酶以及保护神经元的作用。该新型化合物是由以下通式(Ia)或其盐所表示的化合物：其中，R1表示4-羟基-3-甲氧基苯基或类似基团，R2表示1H-吲哚-6-基基或类似基团。
• US8962674B2
  申请人：——

  公开号：US8962674B2

  公开（公告）日：2015-02-24
• Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer’s disease
  作者：Shang-Ying Chen、Yuan Chen、Yan-Ping Li、Shu-Han Chen、Jia-Heng Tan、Tian-Miao Ou、Lian-Quan Gu、Zhi-Shu Huang

  DOI：10.1016/j.bmc.2011.07.033

  日期：2011.9

  A series of novel curcumin analogues were designed, synthesized, and evaluated as potential multifunctional agents for the treatment of AD. The in vitro studies showed that these compounds had better inhibitory properties against A beta aggregation than curcumin. Superior anti-oxidant properties (better than the reference compound Trolox) of these compounds were observed by the oxygen radical absorbance capacity (ORAC) method and a cell-based assay using DCFH-DA as a probe. In addition they were able to chelate metals such as iron and copper and decrease metal-induced A beta aggregation. The structure-activity relationships were discussed. The results suggested that our curcumin analogues could be selected as multifunctional agents for further investigation of AD treatment. (C) 2011 Elsevier Ltd. All rights reserved.